Literature DB >> 28872608

Study on the Fluorescent Activity of N²-Indolyl-1,2,3-triazole.

You-Can Zhang1, Rui Jin2, Luo-Yuan Li3, Zili Chen4, Li-Min Fu5.   

Abstract

A new type of blue emitter, N²-Indolyl-1,2,3-triazoles (NITs), with the λmax ranging from 420-480 nm and the Stokes shift from 89-143 nm, were synthesized through the coupling reaction of indoles with triazole derivatives. The influence of different substitution patterns on the optical properties (efficiency, excitation, and emission wavelengths) of the NITs was investigated. In addition, one palladium complex were synthesized by using NITs as the ligands, which, however, exhibited no fluorescent activity, but did show the enhanced co-planarity. Lastly, two bio-active molecule derivatives were explored for the potential use of these novel dyes in related chemical and biological applications.

Entities:  

Keywords:  N2-aryl-1,2,3-triazoles (NATs); N2-indolyl-1,2,3-triazoles (NITs); blue-emissive fluorophore; fluorescent activity

Mesh:

Substances:

Year:  2017        PMID: 28872608      PMCID: PMC6151483          DOI: 10.3390/molecules22091380

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Photoactive molecules have been the object of many studies in chemistry, biology, and material research [1,2,3,4,5]. A great number of fluorescent compounds emitting different colors (such as red, green, etc.) has been developed over the past years for their utilization in the biological target imaging [6,7,8,9,10,11], effective photosensors [12,13,14,15,16,17], and novel photoactive materials [18,19,20,21,22,23]. However, the corresponding blue-emissive fluorophores, which exhibit blue fluorescence in high quantum efficiency coupled with high stability, are more difficult to obtain [24,25,26,27,28], due to the large energy gaps that exist between the blue emitter’s highest occupied molecular orbitals (HOMOs) and its lowest unoccupied molecular orbitals (LUMOs) [29,30]. This optical activity and photostability dilemma is a great challenge for the development of efficient, stable blue-light-emitting small molecular fluorophores. For example, biphenyl-type molecules and similar structures usually have lower photoactivity, because of the poor conjugation and the ortho-substituted group’s steric repulsions [31,32,33]. On the other hand, extended aromatic systems, in which at least one double bond exists between the aromatic groups, have high quantum efficient blue emission. However, the photolabile double bonds limit their potential applications [34,35,36,37,38]. In 2011, Shi and his coworkers reported N-Aryl-1,2,3-triazoles (NATs, Scheme 1) as a new type of blue-light emitting fluorophore, featured by its tunable optical emission (λmax range from 350–400 nm and Stokes shift from 38–93 nm), with a moderate to good quantum efficiency and a relatively higher stability [39,40]. It was proposed that the blue fluorescence of NAT resulted from a planar intramolecular charge transfer (PICT) mechanism.
Scheme 1

The structure of N-2-Aryl-1,2,3-triazoles (NATs) & N-2-Indolyl-1,2,3-triazoles (NITs).

Recently, we developed a similar molecular structure, N-Indolyl-1,2,3-triazole (NITs) through the N-selective coupling of 1,2,3-triazoles with indoles via iodo-mediation, which are also good blue emitters, with the λmax ranging from 420–480 nm and the Stokes shift from 89–143 nm [41,42]. Starting from this structure, we synthesized a new single-fluorophore-based fluorescent probe for the dual-channel detection of Ag+ and Hg2+ ions [43]. As an extension of the previous research, a series of NITs with different substitution patterns were prepared using the method shown in Scheme 2, and the optical properties of these new blue emitters were investigated in this paper. In addition, one palladium complexes were synthesized by using NITs as ligands, which, however, exhibited no fluorescent activity, but did present enhanced co-planarity.
Scheme 2

Method for the preparation of various substituted N-Indolyl-1,2,3-triazole (NITs).

2. Results and Discussions

The structures of the NITs allowed modification on three different positions: the indole nitrogen atom (R group), the triazole moiety (R1 group), and the indole ring (R2 group) (Scheme 2). To evaluate these new fluorophores, we synthesized compounds 3a–y and explored the influence of different substitution patterns on the optical properties (efficiency, excitation, and emission wavelengths) of the NITs. Influence of the indole N-position: At first, the effect of N-substituted R group was investigated. It was proposed that the fluorescence activity of NATs the was greatly affected by the co-planarity between the phenyl ring and the triazole group (Scheme 1) [39,40]. We considered that R group in NITs, which was located nearby the rotating C-N bond between the indole ring and the triazole group, would affect the co-planarity of NITs, and thus influence their optical properties. The absorption and emission behavior of compounds 3a–e are summarized in Table 1, Figure 1 and Figure 2. A NAT compound, 2,4-diphenyl-2H-1,2,3-triazole (compound 4), was tested as the comparison [39,40], because of its structural similarity with NIT molecules and its synthetic convenience. As shown in Table 1, compound 4 absorbs UV light at 292 nm and emits blue fluorescence at around 345 nm. It was found that the UV absorbance of NITs 3a–e ranged from 298 nm to 325 nm. The peaks of their fluorescence emission had an obvious red-shift compared with 4, which might result from indole group’s stronger electro-donor ability compared to the N-phenyl group of NATs, as well as the larger conjugated system. In addition, all NIT compounds’ Stokes shifts are larger than that of NAT molecule 4.
Table 1

Fluorescence emission behavior of compounds with different Indole N-substitutions (a).

Absorption (nm)Emission (λmax) (nm)Φ (b)Fluorescence Intensity (×103)Stokes Shift
4292 (0.238)3450.3946.353
3a325 (0.246)4290.6528.20104
3b310 (0.238)4370.90128.77127
3c315 (0.219)4320.83105.02117
3d298 (0.312)4220.97136.94124
3e298 (0.258)4230.99109.48125

(a) Sample information: 1.0 × 10−5 mol L−1 in dichloromethane (DCM), excitation at 320 nm with 2.5 nm slit. (b) Quantum yields (Φ) were determined based on 1.0 × 10−5 mol L−1 9,10-Diphenylanthracene in cyclohexane (Ф = 0.95).

Figure 1

The absorption spectra of compounds 3(a–e), 4.

Figure 2

The emission spectra of compounds 3(a–e), 4.

As shown in Table 1, the gradual blue shift of the UV absorbance of 3a–e correlated well with the bulkiness of the corresponding NIT molecule’s indole N-substitution. Compared with indole N-alkyl or phenyl substituted 3b–e (Table 1, entries 3–6), N-unsubstituted compound 3a gave a relative weak fluorescence emission (centered at 429 nm), possibly because of the intense solvation effect of the bare N-H bond in dichloromethane (DCM) [44,45]. The highly steric hindered compounds 3d–e with a bulky N-phenyl group gave similar strong emissions as the much less hindered compounds 3b and 3c, which suggested the small influence of the bulkiness on the indole nitrogen position for the light emission. This effect was also confirmed by the slight red-shift of the emission of 3b–c compared with the fluorescence of 3a. Moreover, the gradual increase in the Stokes shift of 3b–e (from 117–127 nm) indicated a much larger difference between the electronic structure of 3b–e in the ground state and those in the excited state [46]. Notably, the quantum yields of 3b–e were very high; in particular, the quantum yield of 3e reached up to 0.99. Compared with NAT molecule 4, NIT compounds 3a–e presented large, quite interesting Stokes shifts; their electronic structure in the excited state should be conspicuously varied from those in the ground state. In order to determine the NIT molecule’s co-planarity in the ground state, the X-ray crystal structure of compounds 3b and 3h were studied. As shown in Figure 3, the crystal structure of both 3b and 3h exhibited a very large dihedral angle between the indole ring and the triazole ring (see Supplementary Materials). 3h in particular exhibited a dihedral angle of up to 72.64°. These compounds’ real dihedral angles might be different when dissolved in a solution. However, considering that an intramolecular charge transfer emitter always tends to take a more planar-like configuration at its excited state [47,48], the wide dihedral angles shown in Figure 3 partly verified the large Stokes shift exhibited by NIT molecules in Table 1.
Figure 3

X-ray crystal structures of 3b and 3h.

The effect of triazole substituent R1 group (Scheme 2) was then explored. As shown in Table 2, various triazole substitution patterns, such as phenyl (3f–m and 3o–p), thienyl (3n), and alkyl (3q) groups were studied. It was found their UV absorbance ranged from 294 nm to 340 nm (Figure 4), while their fluorescence emission varied from 414 nm to 467 nm (Figure 5). The substituents’ electronegativity would affect the optical properties of the NITs. For example, a slight (10–20 nm) red shift of the fluorescence emission peak and the large Stokes shift of 3l was due to its strong donor-acceptor ability [49,50,51]. The emission peaks of 3i and 3o showed obvious red shifts, because of the presence of an additional ethynyl group (3i) and a planar benzotriazole group (3o). Nevertheless, compared with 3f–p, the UV absorbance and fluorescence emission of alkyl-substituted 3q and unsubstituted 3r have obvious blue shifts, due to the absence of a conjugated phenyl or thienyl group [52,53,54]. The slight red shift of the emission and large Stokes shift of 3m might have resulted from an intramolecular hydrogen bond between the triazole group and the neighboring hydroxyl group. These NIT molecules’ quantum yields ranged between 0.14–0.84. 3o and 3p have relative small quantum yields, while 3k and 3r have much larger quantum yields, though their detailed affecting factors are still not clear.
Table 2

Fluorescence emission behavior of compounds with different triazole-substitutions (a).

Absorption (nm)Emission (λmax) (nm)Φ (b)Fluorescence Intensity (×103)Stokes Shift
3f308 (0.302)4270.71134.75119
3g310 (0.337)4340.4695.14124
3h315 (0.306)4320.4488.16117
3i315 (0.347)4430.62144.93128
3j315 (0.334)4310.73160.55116
3k310 (0.379)4400.80191.11130
3l306 (0.346)4470.67142.66141
3m310 (0.263)4450.5897.74135
3n305 (0.275)4300.69113.77125
3o340 (0.346)4670.1429.77127
3p295 (0.259)4380.2024.8143
3q295 (0.173)4140.5525.78119
3r294 (0.274)4150.8460.6121

(a) Sample information: 1.0 × 10−5 mol L−1 in DCM, excitation at 320 nm with 2.5 nm slit. (b) Quantum yields (Φ) were determined based on 1.0 × 10−5 mol L−1 9,10-Diphenylanthracene in cyclohexane (Ф = 0.95).

Figure 4

The absorption spectra of compounds 3(f–r).

Figure 5

The emission spectra of compounds 3(f–r).

We then explored the effect of the indole ring substituents. As compared with the fluoro group in 3s, the TsO-group and AcNH-group’s low electronegativity as well as their conjugated lone pair improved the donor-acceptor ability of 3t and especially 3u, thus leading to the red shift of their UV absorbance and fluorescence emission (Figure 6 and Figure 7). The small Stokes shift of 3u might be due to its better co-planarity in the ground state. As shown in Table 3, 3v has a little red shift in its UV absorbance and fluorescence emission compared to 3a, while its Stokes shift is lower than that of 3a. An additional N-benzyl group would reduce the co-planarity of 3w in the ground state, and then improve its Stokes shift.
Figure 6

The absorption spectra of compounds 3(s–w).

Figure 7

The emission spectra of compounds 3(f–r).

Table 3

Fluorescence emission behavior of compounds with different indole-substitutions (a).

Absorption (nm)Emission (λmax) (nm)Φ (b)Fluorescence Intensity (×103)Stokes Shift
3s304(0.431)4190.76165.15115
3t310(0.336)4270.73163.18117
3u338(0.126)4270.8561.6289
3v330(0.323)4260.69143.6396
3w299(0.340)4240.86117.16125

(a) Sample information: 1.0 × 10−5 mol L−1 in DCM, excitation at 320 nm with 2.5 nm slit. (b) Quantum yields (Φ) were determined based on 1.0 × 10−5 mol L−1 9,10-Diphenylanthracene in cyclohexane (Ф = 0.95).

We wondered if the metal complexation of the triazole group and the indole nitrogen atom would improve NIT molecules’ co-planarity and affect their optical properties. As shown in Scheme 3, the reactions of NIT molecule 3v with metal salts AuCl3 and Pd(OAc)2 were tested, in which no desired Au(III) metal complex was obtained. However, the reaction of 3v with 1 equivalent of Pd(OAc)2 in CH2Cl2 at room temperature (r.t.) gave a white solid 5 in 45% yield (Scheme 3). As confirmed by its X-ray crystal structure shown in Figure 8, the palladium complex was determined to be a metal complex dimer bridged by two acetates, rather like an open book. In complex 5, it was found that the indole ring, the triazole ring, and the palladium atom almost located in a co-facial arrangement. The geometry around Pd(II) is square planar, composed of two nitrogen atoms from the indole ring and triazole ring, and two oxygen atoms from two bridging acetates. The two NIT ligands are close to parallel in an offset face-to-face stacking mode by a quite small dihedral angle of 0.54°, conforming to an approximate π–π interaction. The resulting Pd1···Pd2 separation of 2.849(2) Å is significantly shorter than the sum of the van der Waals radii of palladium (the typical value of which is 1.6 Å), which reveals a Pd···Pd interaction [55]. Previous studies on double-carboxylato-bridged dinuclear organometallic Pd(II) complexes have shown the possibility of cis-trans isomerism depending on the nature of the ligands [56,57,58]. It has been found that only the trans isomer of complex 5 crystallizes in the asymmetric unit.
Scheme 3

The reaction of 3w with AuCl3 and Pd(OAc)2.

Figure 8

X-ray crystal structure of 5.

However, complex 5 show no fluorescence under UV irradiation, possibly due to the fluorescence quenching by Pd2+ d-d transition. Finally, the optical properties of two bio-active molecule derivatives 3x and 3y were also explored, in which compound 3x was obtained from the reaction of naturally occurring plant auxin indole-3-acetic acid methyl ester with N-1,2,3-phenyl triazole, and 3y was derived from amino acid tryptophan. As shown in Table 4, compounds 3x and 3y absorb strongly at 326–328 nm (Figure 9) and emit vivid blue fluorescence (centered at 418 nm and 430 nm, Figure 10). In sharp contrast, the intrinsic tryptophan units have negligible absorption in the region with a wavelength longer than 320 nm and consequently no fluorescence under 330-nm excitation, which might enable a reliable detection of target biomolecules tagged with the abovementioned fluorescent tryptophan-triazole conjugate 3y without the interference from tryptophan components. Considering the unique UV/blue emission of compound 3y and its analogs, it is a potential new kind of UV fluorescence probe for various chemical and biological studies.
Table 4

Fluorescence emission behavior of compounds 3x and 3y (a).

Absorption (nm)Emission (λmax) (nm)Φ (b)Fluorescence Intensity (×103)Stokes Shift
3x328(0.373)4180.72173.8090
3y326(0.409)4300.60165.49104

(a) Sample information: 1.0 × 10−5 mol L−1 in DCM, excitation at 320 nm with 2.5 nm slit. (b) Quantum yields (Φ) were determined based on 1.0 × 10−5 mol L−1 9,10-Diphenylanthracene in cyclohexane (Ф = 0.95).

Figure 9

The absorption spectra of compounds 3x, 3y, 1y.

Figure 10

The emission spectra of compounds 3x, 3y, 1y.

3. Experimental Section

General procedure for coupling reaction (condition 1) for the synthesis of 3a–3u: To a suspension of N-iodo succinimide (0.3 mmol) and K2CO3 (0.5 mmol) in dry dioxane (1 mL), was added dropwise a solution of 1a (0.2 mmol) and 2a (0.1 mmol) in dioxane (1 mL) in 5 min. 30 min later, the reaction mixture was diluted with 20 mL EtOAc, and was then washed with saturated aqueous Na2S2O3 (5 mL), brine (10 mL) and water (10 mL). The organic phase was dried over anhydrous Na2SO4, filtered and concentrated in vacuo, purification of the crude product through flash chromatography (petroleum/EtOAc = 50/1) afforded 3a as a white solid in 60% yield. 2-(4-Phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3a [41]. Obtained as a white solid in 60% yield; m.p. 128–130 °C; 1H-NMR (400 MHz, CDCl3) δ 9.07 (br, 1H), 8.07 (s, 1H), 7.89 (d, J = 7.1 Hz, 2H), 7.66 (d, J = 7.8 Hz, 1H), 7.49 (t, J = 7.4 Hz, 2H), 7.42 (dd, J = 7.7, 2.8 Hz, 2H), 7.28–7.22 (m, 1H), 7.21–7.15 (m, 1H), 6.90 (d, J = 1.4 Hz, 1H); 13C-NMR (101 MHz, CDCl3) δ 149.05, 134.80, 133.54, 132.82, 129.44, 129.16, 129.06, 127.89, 126.22, 122.86, 121.04, 120.98, 111.20, 90.31. 1-Methyl-2-(4-phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3b [41]. Obtained as a white solid in 64% yield; m.p. 90–91 °C; 1H-NMR (400 MHz, CDCl3) δ 8.11 (s, 1H), 7.88 (d, J = 7.1 Hz, 2H), 7.66 (d, J = 7.9 Hz, 1H), 7.46 (t, J = 7.4 Hz, 2H), 7.38 (dd, J = 12.9, 7.8 Hz, 2H), 7.30 (t, J = 7.1 Hz, 1H), 7.18 (t, J = 6.9 Hz, 1H), 6.84 (s, 1H), 3.83 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 149.08, 135.92, 135.44, 133.02, 129.61, 129.17, 129.10, 126.27, 122.96, 121.41, 120.71, 120.30, 109.83, 96.27, 30.56. 1-Benzyl-2-(4-phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3c [41]. Obtained as a white solid in 72% yield; m.p. 91–92 °C; 1H-NMR (400 MHz, CDCl3) δ 8.01 (s, 1H), 7.77 (d, J = 7.2 Hz, 2H), 7.67 (d, J = 7.6 Hz, 1H), 7.39 (t, J = 7.3 Hz, 2H), 7.34 (d, J = 7.1 Hz, 1H), 7.28 (d, J = 8.1 Hz, 1H), 7.22 (d, J = 6.9 Hz, 1H), 7.20–7.11 (m, 4H), 7.04 (d, J = 7.0 Hz, 2H), 6.92 (s, 1H), 5.57 (s, 2H); 13C-NMR (101 MHz, CDCl3) δ 149.31, 137.45, 135.77, 135.39, 133.09, 129.60, 129.18, 129.10, 128.70, 127.44, 126.60, 126.44, 126.29, 123.30, 121.57, 121.06, 110.62, 96.96, 47.71. 1-Phenyl-2-(4-phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3d. Obtained as a white solid in 57% yield; m.p. 91–93 °C; 1H-NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.92–7.78 (m, 3H), 7.43 (t, J = 20.5 Hz, 11H), 7.15 (s, 1H); 13C-NMR (101 MHz, CDCl3) δ 149.06, 136.91, 136.60, 135.28, 133.03, 129.70, 129.39, 129.08, 128.07, 127.56, 126.27, 123.87, 121.67, 121.63, 111.11, 98.86; IR (neat) 3061, 3028, 1607, 1534, 1461, 1356, 1055, 946, 768, 723, 692, 483 cm−1; HRMS(ESI) m/z calcd. for C22H16N4, [M + H]+ 337.1448, found 337.1444. 1-(4-Methoxyphenyl)-2-(4-phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3e. Obtained as a white solid in 51% yield; m.p. 94–96 °C; 1H-NMR (400 MHz, CDCl3) δ 7.94 (s, 1H), 7.76–7.71 (m, 3H), 7.45–7.39 (m, 2H), 7.37 (d, J = 7.2 Hz, 1H), 7.27–7.22 (m, 5H), 6.97 (s, 1H), 6.91 (d, J = 8.9 Hz, 2H), 3.81 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 159.12, 148.87, 136.81, 135.28, 132.84, 129.51, 129.22, 128.95, 128.79, 126.15, 125.94, 123.56, 121.45, 121.25, 114.38, 110.97, 98.30, 55.56; IR (neat): 3118, 3035, 2924, 1589, 1496, 1454, 1328, 1091, 975, 858, 767, 688, 505cm−1; HRMS (ESI) calcd. for C23H18N4O [M + H]+: 367.1553; Found: 367.1541. 1-Methyl-2-(4-p-tolyl-2H-1,2,3-triazol-2-yl)-1H-indole 3f. Obtained as a white solid in 59% yield; m.p. 94–96 °C; 1H-NMR (400 MHz, CDCl3) δ 8.09 (s, 1H), 7.78 (d, J = 8.1 Hz, 2H), 7.66 (d, J = 7.9 Hz, 1H), 7.38 (d, J = 8.2 Hz, 1H), 7.34–7.25 (m, 3H), 7.19 (t, J = 7.0 Hz, 1H), 6.83 (s, 1H), 3.87 (s, 3H), 2.40 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 149.21, 139.17, 135.89, 135.48, 132.85, 129.76, 126.76, 126.15, 122.88, 121.36, 120.65, 109.79, 96.18, 30.87, 21.44; IR (neat) 3056, 3032, 2931, 1559, 1467, 1331, 1145, 966, 772, 701, 536, 458cm−1; HRMS(ESI) m/z calcd. for C18H16N4, [M + H]+ 289.1448, found 289.1439. 2-(4-(4-Butylphenyl)-2H-1,2,3-triazol-2-yl)-1-methyl-1H-indole 3g. Obtained as a white solid in 52% yield; m.p. 87–89 °C; 1H-NMR (400 MHz, CDCl3) δ 8.07 (s, 1H), 7.78 (d, J = 8.1 Hz, 2H), 7.65 (d, J = 7.9 Hz, 1H), 7.35 (d, J = 8.1 Hz, 1H), 7.27 (t, J = 7.8 Hz, 3H), 7.17 (t, J = 7.4 Hz, 1H), 6.83 (s, 1H), 3.85 (s, 3H), 2.69–2.60 (m, 2H), 1.69–1.56 (m, 2H), 1.43–1.30 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H); 13C-NMR (101 MHz, CDCl3) δ 149.48, 144.22, 135.94, 135.54, 132.88, 129.15, 127.13, 126.20, 122.91, 121.38, 120.68, 109.81, 96.18, 35.58, 33.59, 30.89, 22.42, 14.06; IR (neat) 3059, 3028, 1594, 1523, 1336, 988, 956, 845, 747, 526, 412 cm−1; HRMS(ESI) m/z calcd. for C21H22N4, [M + H]+ 331.1917, found 331.1909. 2-(4-(4-Methoxyphenyl)-2H-1,2,3-triazol-2-yl)-1-methyl-1H-indole 3h. Obtained as a white solid in 60% yield; m.p. 92–93 °C; 1H-NMR (400 MHz, CDCl3) δ 8.05 (s, 1H), 7.82 (d, J = 8.8 Hz, 2H), 7.66 (d, J = 7.9 Hz, 1H), 7.38 (d, J = 8.2 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 6.99 (d, J = 8.8 Hz, 2H), 6.83 (s, 1H), 3.87 (s, 3H), 3.84 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 160.26, 149.09, 135.86, 135.49, 132.51, 127.57, 126.12, 122.82, 122.18, 121.30, 120.60, 114.44, 109.50, 95.96, 55.37, 30.82; IR (neat) 3061, 2986, 1628, 1495, 1441, 1276, 1063, 987, 823, 715, 681, 512cm−1; HRMS(ESI) m/z calcd. for C18H16N4O, [M + H]+ 305.1397, found 305.1387. 1-Benzyl-2-(4-(4-ethynylphenyl)-2H-1,2,3-triazol-2-yl)-1H-indole 3i. Obtained as a white solid in 53% yield; m.p. 108–110 °C; 1H-NMR (400 MHz, CDCl3) δ 8.06 (s, 1H), 7.75 (d, J = 8.0 Hz, 2H), 7.69 (d, J = 7.7 Hz, 1H), 7.55 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.1 Hz, 1H), 7.26–7.15 (m, 5H), 7.05 (d, J = 7.2 Hz, 2H), 6.93 (s, 1H), 5.60 (s, 2H), 3.15 (s, 1H); 13C-NMR (101 MHz, CDCl3) δ 148.36, 137.30, 135.74, 135.14, 133.11, 132.76, 129.83, 128.62, 127.38, 126.45, 126.30, 126.02, 123.31, 122.74, 121.51, 121.01, 110.51, 97.00, 83.26, 78.53, 47.67; IR (neat) 3356, 3069, 3027, 2109, 1612, 1574, 1452, 1326, 956, 811, 707, 652, 485 cm−1; HRMS(ESI) m/z calcd. for C25H18N4, [M + H]+ 375.1604, found 375.1593. 2-(4-(3-Methoxyphenyl)-2H-1,2,3-triazol-2-yl)-1-methyl-1H-indole 3j. Obtained as a white solid in 58% yield; m.p. 102–104 °C; 1H-NMR (400 MHz, CDCl3) δ 8.05 (s, 1H), 7.82 (d, J = 8.3 Hz, 2H), 7.66 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 8.1 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 7.18 (t, J = 7.3 Hz, 1H), 6.99 (d, J = 8.3 Hz, 2H), 6.83 (s, 1H), 3.87 (s, 3H), 3.84 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 160.33, 149.09, 135.85, 135.48, 132.51, 127.56, 126.11, 122.82, 122.18, 121.30, 120.60, 114.20, 109.73, 96.08, 55.37, 30.70; IR (neat) 3059, 2923, 1619, 1486, 1442, 1253, 1072, 986, 836 cm−1; HRMS(ESI) m/z calcd. for C18H16N4O, [M + H]+ 305.1397, found 305.1390. 2-(4-(3-Chlorophenyl)-2H-1,2,3-triazol-2-yl)-1-methyl-1H-indole 3k. Obtained as a white solid in 65% yield; m.p. 88–90 °C; 1H-NMR (400 MHz, CDCl3) δ 8.04 (s, 1H), 7.86 (s, 1H), 7.69 (td, J = 4.0, 1.5 Hz, 1H), 7.64 (d, J = 7.9 Hz, 1H), 7.36–7.26 (m, 4H), 7.17 (t, J = 6.7 Hz, 1H), 6.82 (s, 1H), 3.82 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 147.79, 135.83, 135.11, 134.93, 132.89, 131.24, 130.21, 128.96, 126.14, 125.93, 124.17, 122.94, 121.30, 120.66, 109.73, 96.19, 30.81; IR (neat) 3062, 3016, 1703, 1561, 1467, 1352, 1266, 1056, 956, 796, 737, 628 cm−1; HRMS(ESI) m/z calcd. for C17H13ClN4, [M + H]+ 309.0902, found 309.0893. 2-(4-(3-Fluorophenyl)-2H-1,2,3-triazol-2-yl)-1-methyl-1H-indole 3l. Obtained as a white solid in 62% yield; m.p. 80–82 °C; 1H-NMR (400 MHz, CDCl3) δ 8.11 (s, 1H), 7.66 (t, J = 7.7 Hz, 2H), 7.61 (dd, J = 9.6, 2.0 Hz, 1H), 7.46–7.36 (m, 2H), 7.32 (t, J = 7.6 Hz, 1H), 7.19 (t, J = 7.4 Hz, 1H), 7.09 (td, J = 8.4, 2.5 Hz, 1H), 6.85 (s, 1H), 3.88 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 164.45, 162.00, 148.14, 135.92, 135.21, 133.03, 131.70 (d, J = 8.4 Hz), 130.67 (d, J = 8.3 Hz), 126.03, 123.03, 121.85 (d, J = 2.4 Hz), 121.40, 120.73, 116.96 (d, J = 21.3 Hz), 113.16 (d, J = 23.0 Hz), 109.79, 96.35, 30.87; IR (neat) 3059, 3036, 1601, 1553, 1492, 1352, 1231, 1142, 956, 843, 737, 628, 503 cm−1; HRMS(ESI) m/z calcd. for C17H13FN4, [M + H]+ 293.1197, found 293.1191. 2-(2-(1-Methyl-1H-indol-2-yl)-2H-1,2,3-triazol-4-yl)phenol 3m. Obtained as a white solid in 47% yield; m.p. 132–135 °C; 1H-NMR (400 MHz, CDCl3) δ 9.46 (s, 1H), 8.25 (s, 1H), 7.69 (d, J = 7.6 Hz, 2H), 7.41 (d, J = 8.2 Hz, 1H), 7.38–7.30 (m, 2H), 7.22 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 8.2 Hz, 1H), 7.02 (t, J = 7.5 Hz, 1H), 6.85 (s, 1H), 3.86 (s, 3H); 1H-NMR (400 MHz, CDCl3): δ 9.47 (s, 1H), 8.26 (s, 1H), 7.69 (d, J = 8.0 Hz, 2H), 7.42 (d, J = 8.2 Hz, 1H), 7.38–7.33 (m, 2H), 7.23 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 8.3 Hz, 1H), 7.03 (t, J = 7.4 Hz, 1H) 6.85 (s, 1H), 3.87 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 155.42, 154.18, 135.86, 132.78, 130.95, 126.66, 123.34, 121.43, 120.92, 120.08, 117.63, 109.86, 96.80, 88.55, 86.71, 30.82; IR (neat) 3108, 3049, 2986, 1663, 1564, 1474, 1366, 996, 757, 727, 691 cm−1; HRMS(ESI) m/z calcd. for C17H14N4O, [M + H]+ 291.1240, found 291.1236. 1-Methyl-2-(4-(thiophen-3-yl)-2H-1,2,3-triazol-2-yl)-1H-indole 3n. Obtained as a white solid in 51% yield; m.p. 92–94 °C; 1H-NMR (400 MHz, CDCl3) δ 7.97 (s, 1H), 7.70 (d, J = 2.0 Hz, 1H), 7.64 (d, J = 7.9 Hz, 1H), 7.51 (d, J = 4.8 Hz, 1H), 7.39–7.36 (m, 1H), 7.34 (d, J = 8.2 Hz, 1H), 7.28 (t, J = 7.5 Hz, 1H), 7.17 (t, J = 7.3 Hz, 1H), 6.82 (s, 1H), 3.82 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 145.31, 135.82, 135.26, 133.09, 130.85, 126.73, 126.03, 125.91, 122.87, 122.61, 121.30, 120.61, 109.72, 96.24, 30.44; IR (neat) 3033, 2932, 1586, 1454, 1336, 1189, 965, 873, 769, 715; HRMS(ESI) m/z calcd. for C15H12N4S, [M + H]+ 281.0855, found 281.0847. 2-(1-Methyl-1H-indol-2-yl)-2H-benzo[d][1,2,3]triazole 3o. Obtained as a white solid in 54% yield; m.p. 137–139 °C; 1H-NMR (400 MHz, CDCl3) δ 7.95 (dd, J = 6.6, 3.1 Hz, 2H), 7.70 (d, J = 7.9 Hz, 1H), 7.50–7.38 (m, 3H), 7.34 (t, J = 7.5 Hz, 1H), 7.21 (t, J = 7.1 Hz, 1H), 7.06 (s, 1H), 4.00 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 144.93, 136.51, 135.80, 127.48, 126.06, 123.41, 121.59, 120.89, 118.31, 109.79, 97.65, 31.44; IR (neat) 3052, 3028, 1568, 1452, 1346, 1271, 1059, 956, 771, 732, 692 cm−1; HRMS(ESI) m/z calcd. for C15H12N4, [M + H]+ 249.1135, found 249.1124. 1-Benzyl-2-(4-bromo-5-phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3p. Obtained as a white solid in 53% yield; m.p. 90–91 °C; 1H-NMR (400 MHz, CDCl3) δ 7.92 (d, J = 6.5 Hz, 2H), 7.70 (d, J = 7.8 Hz, 1H), 7.50–7.40 (m, 3H), 7.34 (d, J = 8.1 Hz, 1H), 7.28 (d, J = 7.0 Hz, 1H), 7.24–7.17 (m, 4H), 7.05 (d, J = 6.6 Hz, 2H), 6.93 (s, 1H), 5.61 (s, 2H); 13C-NMR (101 MHz, CDCl3) δ 146.99, 137.07, 135.75, 134.54, 129.39, 128.71, 128.64, 128.32, 127.50, 127.45, 126.77, 126.51, 126.11, 123.52, 121.62, 121.08, 110.51, 97.33, 47.65; IR (neat) 3059, 3030, 2924, 1558, 1454, 1328, 1161, 1010, 956, 727, 694cm−1; HRMS (ESI) Calcd. for C23H18BrN4 [M + H]+: 429.07094; Found: 429.06996. 1-Benzyl-2-(4-butyl-2H-1,2,3-triazol-2-yl)-1H-indole 3q [41]. Obtained as a colorless oil in 60% yield; 1H-NMR (400 MHz, CDCl3) δ 7.59 (d, J = 7.7 Hz, 1H), 7.51 (s, 1H), 7.22 (d, J = 8.0 Hz, 1H), 7.18–7.05 (m, 5H), 6.94 (d, J = 6.9 Hz, 2H), 6.74 (s, 1H), 5.46 (s, 2H), 2.66 (t, J = 7.7 Hz, 2H), 1.83-1.46 (m, 2H), 1.36–1.20 (m, 2H), 0.85 (t, J = 7.3 Hz, 3H); 13C-NMR (101 MHz, CDCl3) δ 150.56, 137.32, 135.46, 134.87, 128.54, 127.28, 126.49, 126.38, 122.96, 121.37, 120.77, 110.44, 96.66, 47.42, 31.09, 25.14, 22.15, 13.75. 1-Benzyl-2-(2H-1,2,3-triazol-2-yl)-1H-indole 3r [41]. Obtained as a white solid in 95% yield; m.p. 95–98 °C; 1H-NMR (400 MHz, CDCl3) δ 7.76 (s, 2H), 7.61 (d, J = 7.7 Hz, 1H), 7.22 (d, J = 8.2 Hz, 1H), 7.17–7.07 (m, 5H), 6.94 (d, J = 6.7 Hz, 2H), 6.80 (s, 1H), 5.45 (s, 2H); 13C-NMR (101 MHz, CDCl3) δ 137.16, 135.97, 135.51, 135.14, 128.69, 127.37, 126.43, 126.25, 123.24, 121.58, 120.92, 110.43, 97.20, 47.57. 5-Fluoro-2-(4-phenyl-2H-1,2,3-triazol-2-yl)-1H-indole 3s [41]. Obtained as a white solid in 78% yield; m.p. 116–119 °C; 1H-NMR (400 MHz, CDCl3) δ 8.08 (s, 1H), 7.81 (d, J = 7.0 Hz, 2H), 7.48–7.38 (m, 3H), 7.33 (dd, J = 9.2, 2.4 Hz, 1H), 7.26–7.18 (m, 4H), 7.06 (d, J = 6.6 Hz, 2H), 6.98 (td, J = 9.1, 2.5 Hz, 1H), 6.89 (s, 1H), 5.61 (s, 2H); 13C-NMR (101 MHz, CDCl3) δ 158.46(d, J = 235.9 Hz), 149.40, 137.06, 136.43, 133.17, 132.19, 129.38, 129.19, 129.04, 128.69, 127.50, 126.70, 126.59, 126.45, 126.22, 111.84, 111.53 (d, J = 9.5 Hz), 111.39, 106.24(d, J = 23.6 Hz), 96.72(d, J = 4.5 Hz), 96.69, 47.85. 1-Benzyl-2-(4-phenyl-2H-1,2,3-triazol-2-yl)-1H-indol-5-yl-4-methylbenzenesulfonate 3t [41]. Obtained as a white solid in 83% yield; m.p. 169–171 °C; 1H-NMR (400 MHz, CDCl3) δ 8.07 (s, 1H), 7.80 (d, J = 6.9 Hz, 2H), 7.70 (d, J = 8.3 Hz, 2H), 7.48–7.36 (m, 3H), 7.28 (d, J = 8.1 Hz, 2H), 7.25–7.18 (m, 5H), 7.04 (d, J = 6.3 Hz, 2H), 6.89 (dd, J = 8.9, 2.3 Hz, 1H), 6.84 (s, 1H), 5.58 (s, 2H), 2.43 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 149.50, 145.15, 144.25, 136.78, 136.42, 133.98, 133.28, 132.48, 129.71, 129.26, 129.06, 128.70, 128.64, 127.58, 126.50, 126.22, 123.62, 118.06, 114.65, 111.24, 97.07, 47.96, 21.76. N-(1-Benzyl-2-(4-phenyl-2H-1,2,3,-triazol-2-yl)-1H-indol-5-yl)acetamide 3u [41]. Obtained as a white solid in 60% yield; m.p. 128–131 °C; 1H-NMR (400 MHz, CDCl3) δ 8.06 (s, 1H), 7.87 (br, 1H), 7.80 (d, J = 7.2 Hz, 2H), 7.51–7.36 (m, 4H), 7.30–7.15 (m, 5H), 7.04 (d, J = 6.8 Hz, 2H), 6.87 (s, 1H), 5.58 (s, 2H), 2.17 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 168.44, 149.27, 137.20, 135.88, 133.04, 131.50, 129.43, 129.13, 129.02, 128.63, 127.40, 126.46, 126.21, 117.51, 113.23, 110.78, 96.88, 47.77, 24.49. General procedure for coupling reaction (condition 2) for the synthesis of 3v–3y: To a suspension of 1v (0.1 mmol), 2a (0.2 mmol) in dry dioxane (1 mL), was added 0.1 mL CHCl3, and then added dropwise a solution of N-iodosuccinimide (0.3 mmol) in dioxane (1 mL) in 5 min. 30 min later, the reaction mixture was diluted with 20 mL EtOAc, and was washed with saturated aqueous Na2S2O3 (5 mL), brine (10 mL) and water (10 mL). The organic phase was dried over anhydrous Na2SO4, filtered and concentrated in vacuo, purification of the crude product through flash chromatography (petroleum/EtOAc = 50/1 as the eluent) afforded 3v as a white solid. 3-Methyl-2-(4-phenyl-2H-1,2,3,-triazol-2-yl)-1H-indole 3v [41]. Obtained as a white solid in 55% yield; m.p. 132–134 °C; 1H-NMR (400 MHz, CDCl3) δ 8.88 (br, 1H), 8.03 (s, 1H), 7.86 (d, J = 5.3 Hz, 2H), 7.60 (d, J = 7.8 Hz, 1H), 7.45 (t, J = 7.4 Hz, 2H), 7.41–7.35 (m, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.23 (t, J = 7.0 Hz, 1H), 7.17 (t, J = 7.0 Hz, 1H), 2.66 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 148.41, 132.86, 132.15, 130.67, 129.67, 129.14, 129.05, 129.02, 126.17, 123.07, 120.22, 119.38, 110.88, 100.67, 9.02. 1-Benzyl-3-methyl-2-(4-phenyl-2H-1,2,3,-triazol-2-yl)-1H-indole 3w [41]. Obtained as a white solid in 75% yield; m.p. 78–80 °C; 1H-NMR (400 MHz, CDCl3) δ 8.09 (s, 1H), 7.81 (d, J = 7.0 Hz, 2H), 7.66 (d, J = 7.8 Hz, 1H), 7.43 (t, J = 7.3 Hz, 2H), 7.40–7.34 (m, 1H), 7.30–7.23 (m, 2H), 7.21–7.13 (m, 4H), 7.03 (d, J = 6.4 Hz, 2H), 5.26 (s, 2H), 2.36 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 149.24, 137.35, 134.70, 133.01, 131.66, 129.69, 129.09, 129.07, 128.60, 127.39, 126.90, 126.68, 126.26, 123.67, 120.17, 119.99, 110.33, 107.43, 47.18, 8.39. Methyl 2-(1-benzyl-2-(4-phenyl-2H-1,2,3,-triazol-2-yl)-1H-indol-3-yl)acetate 3x [41]. Obtained as a white solid in 67% yield; m.p. 104–106 °C; 1H-NMR (400 MHz, CDCl3) δ 8.11 (s, 1H), 7.82 (d, J = 7.0 Hz, 2H), 7.69 (d, J = 7.8 Hz, 1H), 7.45 (t, J = 7.3 Hz, 2H), 7.42–7.37 (m, 1H), 7.33–7.27 (m, 2H), 7.24–7.18 (m, 4H), 7.06 (d, J = 6.6 Hz, 2H), 5.42 (s, 2H), 3.91 (s, 2H), 3.63 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 171.49, 149.37, 137.06, 134.65, 133.19, 132.61, 129.49, 129.14, 129.03, 128.61, 127.41, 126.62, 126.23, 123.76, 120.82, 119.90, 110.55, 103.39, 52.09, 47.46, 29.79. (S)-Methyl 2-acetamido-3-(2-(4-phenyl-2H-1,2,3,-triazol-2-yl)-1H-indol-3-yl) propanoate 3y [41]. Obtained as a yellow solid in 62% yield, = +15.1 (c = 1.00); m.p. 137–140 °C; 1H-NMR (400 MHz, DMSO) δ 12.10 (br, 1H), 8.74 (s, 1H), 8.47 (d, J = 7.6 Hz, 1H), 8.06 (d, J = 7.2 Hz, 2H), 7.64 (d, J = 7.9 Hz, 1H), 7.56 (t, J = 7.5 Hz, 2H), 7.50–7.42 (m, 2H), 7.20 (t, J = 7.5 Hz, 1H), 7.11 (t, J = 7.4 Hz, 1H), 4.69 (q, J = 7.5 Hz, 1H), 3.64 (dd, J = 13.9, 7.4 Hz, 1H), 3.44 (s, 3H), 3.37 (dd, J = 13.9, 7.5 Hz, 1H), 1.77 (s, 3H); 13C-NMR (101 MHz, DMSO) δ 172.82, 169.65, 148.85, 133.76, 133.60, 131.78, 129.63, 129.58, 128.12, 126.49, 125.90, 122.93, 120.23, 119.27, 112.15, 100.02, 53.34, 52.10, 26.63, 22.76. Synthetic procedure for compound 5: A solution of 3v (0.05 mmol) and Pd(OAc)2 (0.05 mmol) in dry CH2Cl2 (1 mL) was stirred at room temperature for 2 h. After filtration, slow evaporation of the resulting solution gave a colorless crystal 5. Compound 5. Obtained as a yellow solid in 45% yield, 1H-NMR (400 MHz, CDCl3) δ 7.43–7.38 (m, 1H), 7.36 (dt, J = 7.8, 3.8 Hz, 1H), 7.01–6.94 (m, 1H), 6.72 (d, J = 8.0 Hz, 1H), 6.61 (ddd, J = 7.9, 5.2, 2.7 Hz, 1H), 6.57 (s, 1H), 2.38 (s, 1H), 2.30 (s, 1H); 13C-NMR (101 MHz, CDCl3) δ 193.64, 186.49, 180.98, 173.69, 161.51, 129.30, 128.48, 126.61, 126.02, 121.68, 119.74, 117.96, 111.80, 98.63, 23.79, 7.65.4.

4. Conclusions

In conclusion, N-2-indolyl-triazoles (NITs) are a novel class of effective UV/blue-light-emitting dyes. Through a comprehensive comparison of the substituted groups on the indole nitrogen atom, the indole group, and the triazole group, a general trend was revealed regarding how to effectively adjust the photoactivity of these compounds. Both emission wavelengths (410–470 nm) and Stokes shifts (89–143 nm) could be adjusted with various substituted functional groups. We hope that further derivatizations of these NIT molecules would gave highly efficient UV-emitting biocompatible amino acid NIT probes, thus supporting the potential use of these novel dyes in related chemical, material, and biological applications.
  37 in total

1.  Fast intramolecular charge transfer with a planar rigidized electron donor/acceptor molecule.

Authors:  Toshitada Yoshihara; Sergey I Druzhinin; Klaas A Zachariasse
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

2.  Hairpin DNA-functionalized gold colloids for the imaging of mRNA in live cells.

Authors:  Ashwath Jayagopal; Kristin C Halfpenny; Jonas W Perez; David W Wright
Journal:  J Am Chem Soc       Date:  2010-07-21       Impact factor: 15.419

3.  A microbead array chemical sensor using capillary-based sample introduction: toward the development of an "electronic tongue".

Authors:  Young-Soo Sohn; Adrian Goodey; Eric V Anslyn; John T McDevitt; Jason B Shear; Dean P Neikirk
Journal:  Biosens Bioelectron       Date:  2004-12-02       Impact factor: 10.618

4.  Solution self-assembly, spontaneous deprotonation, and crystal structures of bipyrazolate-bridged metallomacrocycles with dimetal centers.

Authors:  Shu-Yan Yu; Hai-Ping Huang; Sheng-Hui Li; Qing Jiao; Yi-Zhi Li; Biao Wu; Yoshihisa Sei; Kentaro Yamaguchi; Yuan-Jiang Pan; Hong-Wei Ma
Journal:  Inorg Chem       Date:  2005-12-12       Impact factor: 5.165

5.  Self-assembling nanoprobes that display off/on 19F nuclear magnetic resonance signals for protein detection and imaging.

Authors:  Yousuke Takaoka; Takashi Sakamoto; Shinya Tsukiji; Michiko Narazaki; Tetsuya Matsuda; Hidehito Tochio; Masahiro Shirakawa; Itaru Hamachi
Journal:  Nat Chem       Date:  2009-09-23       Impact factor: 24.427

6.  Effect of the orientation of donor and acceptor on the probability of energy transfer involving electronic transitions of mixed polarization.

Authors:  E Haas; E Katchalski-Katzir; I Z Steinberg
Journal:  Biochemistry       Date:  1978-11-14       Impact factor: 3.162

7.  Synthesis and characterization of bis-N-2-aryl triazole as a fluorophore.

Authors:  Yanwei Zhang; Xiaohan Ye; Jeffery L Petersen; Minyong Li; Xiaodong Shi
Journal:  J Org Chem       Date:  2015-03-20       Impact factor: 4.354

8.  Molecular optical switches: synthesis, structure, and photoluminescence of spirosila compounds.

Authors:  Duanchao Yan; Javad Mohsseni-Ala; Norbert Auner; Michael Bolte; Jan W Bats
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

9.  Strength enhancement of nanostructured organogels through inclusion of phthalocyanine-containing complementary organogelator structures and in situ cross-linking by click chemistry.

Authors:  David Díaz Díaz; Juan José Cid; Purificación Vázquez; Tomás Torres
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

10.  Highly N2-selective coupling of 1,2,3-triazoles with indole and pyrrole.

Authors:  Jian Wen; Li-Li Zhu; Qing-Wei Bi; Zhu-Qing Shen; Xiao-Xiao Li; Xin Li; Zhen Wang; Zili Chen
Journal:  Chemistry       Date:  2013-12-16       Impact factor: 5.236

View more
  2 in total

Review 1.  Metal-free multicomponent approach for the synthesis of propargylamine: a review.

Authors:  Sujit Ghosh; Kinkar Biswas
Journal:  RSC Adv       Date:  2021-01-07       Impact factor: 3.361

2.  Aurone-derived 1,2,3-triazoles as potential fluorescence molecules in vitro.

Authors:  Daniel L Bryant; Arjun Kafle; Scott T Handy; Anthony L Farone; Justin M Miller
Journal:  RSC Adv       Date:  2022-08-12       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.